Companies / BOC Sciences / Amatuximab
BOC Sciences

Amatuximab | BOC Sciences

Amatuximab is a humanized monoclonal antibody directed to mesothelin that kills mesothelin-expressing tumor cells by antibody-dependent cell-mediated cytotoxicity. Amatuximab blocks the binding of mesothelin to CA 125 and thus could be used also as a strategy to prevent tumor metastasis.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.